A preliminary look at data from hospitalized adults diagnosed with COVID-19 in a randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir is showing promising results.
A preliminary look at data from hospitalized adults diagnosed with COVID-19 in a randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir is showing promising results.